Alnylam Sweden AB
559086-6686ActiveLeading RNAi therapeutics company developing gene-silencing medicines.
Yleiskatsaus
- 5–9
- Työntekijät
- 100–500milj SEK
- Liikevaihto
- 2016
- Perustettu
Avainpäättäjät
Christine Akinc
Chief Corporate Communications Officer
Jeff Poulton
Chief Financial Officer
Hiroshi Okada
President, Alnylam Japan
Bryan Supran
Chief Legal Officer
+26 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Alnylam Pharmaceuticals is a leading global biopharmaceutical company dedicated to pioneering RNA interference (RNAi) therapeutics. They focus on developing an innovative class of medicines designed to treat diseases by silencing the specific genes responsible for causing them. This mechanism target...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Partihandel med medicinsk utrustning och apoteksvaror
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559086668601
Päättäjät
30 yhteystietoa FunnelfeedrissäChristine Akinc
Chief Corporate Communications Officer
Jeff Poulton
Chief Financial Officer
Hiroshi Okada
President, Alnylam Japan
Bryan Supran
Chief Legal Officer
Pushkal Garg
Chief Research and Development Officer
Stuart A. Arbuckle
Board Member
Peter N. Kellogg
Board Member
Tolga Tanguler
Chief Commercialization Officer
Lena Geltenbort-Rost
Director, TTR/Amyloidosis International Region
Kevin Fitzgerald
Chief Scientific Officer
Margaret A. Hamburg
Board Member
Timothy Maines
Chief Technical Operations and Quality Officer
Elliott Sigal
Board Member
Heather Sun
Senior Director, Medical Information and Review
Yvonne Greenstreet
Chief Executive Officer
Dennis A. Ausiello
Board Member
Amy W. Schulman
Chair
FRAN KOCHMAN
Senior Director, TTR/Amyloidosis
Melissa McLaughlin
Chief Human Resources Officer
AIKO MIURA
Associate Director, Asia Pacific Region
Benjamin F. Cravatt
Board Member
Piyush Sharma
Chief Ethics & Compliance Officer
Olivier Brandicourt
Board Member
Greg Robertson
Senior Director, Global Rare Diseases
Colleen F. Reitan
Board Member
David E.I. Pyott
Board Member
Sandra (Sandy) Waite
Chief Communications Officer
Muut yhteyshenkilöt
Jeffrey Vernon Poulton
Media Contact
Katarzyna Maria Witkos
Media Contact
Carlos Pagnano
Media Contact
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäAlexion Pharma Nordics AB
10–19 työntekijätPioneering transformative medicines for the global rare disease community.
Purpose Pharma International AB
4 työntekijätDeveloping and supplying rare disease treatments across Europe.
PTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
ASTRAZENECA PLC
1–4 työntekijätGlobal science-led pharmaceutical business developing life-changing medicines.
ScandiBio Therapeutics AB
0 työntekijätAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Selaa lisää
Kysymyksiä yrityksestä Alnylam Sweden AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo